Skip to contentI
INSMED Inc
I
INSMINSMED Inc Q1 2023 · 10-Q
Revenue$65.21M$65.21M+22.8% vs Q1 2022 Net Income-$159.76M-$159.76MN/M vs Q1 2022 EPS Diluted-$1.17-$1.17N/M vs Q1 2022 Operating Income-$148,158,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
Free Cash Flowderived-$149,701,000N/M Margins · derivedOperating margin-227.2%−58.0 pt vs Q1 2022
Net margin-245.0%−66.8 pt vs Q1 2022
ended Mar 31, 2023 · filed May 4, 2023 · 34 d after period end